156 related articles for article (PubMed ID: 15866463)
1. Induction of genotoxic and cytotoxic damage by aclarubicin, a dual topoisomerase inhibitor.
Hajji N; Mateos S; Pastor N; Domínguez I; Cortés F
Mutat Res; 2005 May; 583(1):26-35. PubMed ID: 15866463
[TBL] [Abstract][Full Text] [Related]
2. Modulation of radiation response by inhibiting topoisomerase II catalytic activity.
Mateos S; Hajji N; Pastor N; Cortés F
Mutat Res; 2006 Jul; 599(1-2):105-15. PubMed ID: 16574164
[TBL] [Abstract][Full Text] [Related]
3. Activity of topoisomerase inhibitors daunorubicin, idarubicin, and aclarubicin in the Drosophila Somatic Mutation and Recombination Test.
Lehmann M; Vilar Kde S; Franco A; Reguly ML; Rodrigues de Andrade HH
Environ Mol Mutagen; 2004; 43(4):250-7. PubMed ID: 15141364
[TBL] [Abstract][Full Text] [Related]
4. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
Smith LM; Willmore E; Austin CA; Curtin NJ
Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
[TBL] [Abstract][Full Text] [Related]
5. A novel use for the comet assay: detection of topoisomerase II inhibitors.
Salti GI; Das Gupta TK; Constantinou AI
Anticancer Res; 2000; 20(5A):3189-93. PubMed ID: 11062742
[TBL] [Abstract][Full Text] [Related]
6. Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells.
Snyder RD
Environ Mol Mutagen; 2000; 35(1):13-21. PubMed ID: 10692223
[TBL] [Abstract][Full Text] [Related]
7. Additive and supraadditive interaction between ionizing radiation and pazelliptine, a DNA topoisomerase inhibitor, in Chinese hamster V-79 fibroblasts.
Balosso J; Giocanti N; Favaudon V
Cancer Res; 1991 Jun; 51(12):3204-11. PubMed ID: 1645614
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase I/II selectivity among derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA).
Bridewell DJ; Finlay GJ; Baguley BC
Anticancer Drug Des; 2001 Dec; 16(6):317-24. PubMed ID: 12375884
[TBL] [Abstract][Full Text] [Related]
9. Differential actions of aclarubicin and doxorubicin: the role of topoisomerase I.
Bridewell DJ; Finlay GJ; Baguley BC
Oncol Res; 1997; 9(10):535-42. PubMed ID: 9507531
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-induced endoreduplication in CHO cells: DNA damage and inhibition of topoisomerase II.
Cantero G; Pastor N; Mateos S; Campanella C; Cortés F
Mutat Res; 2006 Jul; 599(1-2):160-6. PubMed ID: 16574165
[TBL] [Abstract][Full Text] [Related]
11. The mycotoxin ochratoxin A inhibits DNA topoisomerase II and induces polyploidy in cultured CHO cells.
Cosimi S; Orta L; Mateos S; Cortés F
Toxicol In Vitro; 2009 Sep; 23(6):1110-5. PubMed ID: 19490938
[TBL] [Abstract][Full Text] [Related]
12. Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid.
De Graff WG; Myers LS; Mitchell JB; Hahn SM
Int J Oncol; 2003 Jul; 23(1):159-63. PubMed ID: 12792789
[TBL] [Abstract][Full Text] [Related]
13. The effect of two topoisomerase inhibitors on low-dose hypersensitivity and increased radioresistance in Chinese hamster V79 cells.
Skov K; Zhou H; Marples B
Radiat Res; 1994 Apr; 138(1 Suppl):S117-20. PubMed ID: 8146313
[TBL] [Abstract][Full Text] [Related]
14. Protection of halogenated DNA from strand breakage and sister-chromatid exchange induced by the topoisomerase I inhibitor camptothecin.
Orta ML; Mateos S; Cantero G; Wolff LJ; Cortés F
Mutat Res; 2008 Jan; 637(1-2):40-8. PubMed ID: 17706727
[TBL] [Abstract][Full Text] [Related]
15. F 11782, a novel catalytic inhibitor of topoisomerases I and II, induces atypical, yet cytotoxic DNA double-strand breaks in CHO-K1 cells.
Barret JM; Etiévant C; Baudouin C; Skov K; Charvéron M; Hill BT
Anticancer Res; 2002; 22(1A):187-92. PubMed ID: 12017285
[TBL] [Abstract][Full Text] [Related]
16. The influence of DNA-topoisomerase II inhibitors novobiocin and fostriecin on the induction and repair of DNA damage in Chinese hamster ovary (CHO) cells treated with mitoxantrone.
Stĕtina R; Veselá D
Neoplasma; 1991; 38(1):109-17. PubMed ID: 1849236
[TBL] [Abstract][Full Text] [Related]
17. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
[TBL] [Abstract][Full Text] [Related]
18. Endoreduplication induced in cultured Chinese hamster cells by different anti-topoisomerase II chemicals. Evidence for the essential contribution of the enzyme to chromosome segregation.
Pastor N; Cantero G; Campanella C; Cortés F
Mutat Res; 2005 Apr; 582(1-2):11-9. PubMed ID: 15781205
[TBL] [Abstract][Full Text] [Related]
19. DNA repair enzyme, O6-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors.
Kuo CC; Liu JF; Chang JY
J Pharmacol Exp Ther; 2006 Feb; 316(2):946-54. PubMed ID: 16258022
[TBL] [Abstract][Full Text] [Related]
20. Identification of anthracenyl-dipeptide conjugates as novel topoisomerase I and II inhibitors and their evaluation as potential anticancer drugs.
Meikle I; Cummings J; Macpherson JS; Smyth JF
Anticancer Drug Des; 1995 Oct; 10(7):515-27. PubMed ID: 7495476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
